Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Finasteride effectively treats male hair loss, improving growth and density.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The document concludes that more research is needed to fully understand the causes of PCOS.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Women with excessive hair growth often have hormonal issues and need medical advice and treatment.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Minoxidil and spironolactone slow hair loss in women.

Stopping aripiprazole can reverse its side effect of hair loss.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

PCOS and lifestyle choices like diet and hair removal methods play a key role in moderate hirsutism.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Understanding and treating alopecia areata improves patient care.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.